Telnyx Launches “LiveKit on Telnyx” for Deploying Voice AI Agents with Lower Cost and Ultra-Low Latency Vida Health Launches the Most Comprehensive Virtual Care Solution for Small Businesses
The new package lets small employers provide employees with Vida’s comprehensive, all-in-one healthcare solution for…
Trace3 Acquires LaSalle Solutions to Enhance Client Life Cycle Services and Geographic Coverage
LaSalle to benefit from elite engineering and emerging tech expertise of Trace3 IRVINE, Calif.–(BUSINESS WIRE)–Trace3…
VanEck Launches Digital Assets Mining ETF (DAM), Providing Access to the Builders of the Blockchain
Digital asset miners are integral to the digital asset economy and represent the largest—and a…
Verint Announces Newly Elected Board Member
Kristen Robinson Brings Expertise in Employee Experience, Global Talent Management, and Diversity, Equity and Inclusion…
AST SpaceMobile Announces Multi-Launch Agreement With SpaceX for Planned Direct-to-Cell Phone Connectivity
MIDLAND, Texas–(BUSINESS WIRE)–$ASTS #5G—AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first…
Flux Power to Participate & Unveil Two New Lithium-Ion Battery Packs at MODEX 2022 on March 28-31, 2022
New Product Introductions Position Company to Offer Solutions for the Three-Wheel Forklift and Autonomous Mobile…
Customers Give Verint Top Scores in New Workforce Optimization Market Report
MELVILLE, N.Y.–(BUSINESS WIRE)–#AI—Verint® (Nasdaq: VRNT), The Customer Engagement Company™, today announced that it has received…
Paysend And Banco Rendimento Unite to Provide Faster and More Affordable Money Transfers to Brazil Via Pix
LONDON – 09 MARCH, 2022 – Paysend, the card-to-card pioneer and international payments platform, today…
Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas
The company reiterates full year 2022 guidance SEATTLE, March 09, 2022 (GLOBE NEWSWIRE) — Adaptive…
EyePoint Pharmaceuticals Announces Debt Refinancing with $45M Credit Facilities from Silicon Valley Bank
New structure replaces existing facility with a significant interest rate reduction resulting in approximately $2.8…
BioXcel Therapeutics to Present at the Barclays Global Healthcare Conference
NEW HAVEN, Conn., March 09, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
Medicenna Announces Upcoming Poster Presentations at the AACR Annual Meeting
TORONTO and HOUSTON, March 09, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics
CHATHAM, N.J., March 09, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Better Choice Company to Host Fourth Quarter and Fiscal Year 2021 Earnings Call on March 29th at 8:30 a.m. ET
NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice”…
TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities
Received FDA clearance of IND for TSC-100 for the treatment of hematologic malignancies Phase 1…
Cyclacel Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conference
BERKELEY HEIGHTS, N.J., March 09, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;…
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Data presented from ongoing Phase 1 clinical trial of ONCR-177 in multiple solid tumor indications…
TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
— Preclinical results from Georgetown University support that SM-88 is potentially a novel anti-cancer agent…
Cincinnati Children’s Hospital Medical Center and Orange Grove Bio Establish Collaboration to Develop and Commercialize Novel Therapeutics
CINCINNATI, March 09, 2022 (GLOBE NEWSWIRE) — Orange Grove Bio, a preclinical drug investment and…
Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC™ Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022
Treatment with GeneTAC™ Small Molecules Reduced Nuclear Foci and Restored Normal Splicing In Vitro, Supporting…